VestGen Advisors LLC boosted its stake in UiPath, Inc. (NYSE:PATH - Free Report) by 1,090.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 165,091 shares of the company's stock after purchasing an additional 151,219 shares during the period. VestGen Advisors LLC's holdings in UiPath were worth $2,120,000 at the end of the most recent quarter.
Other hedge funds have also recently added to or reduced their stakes in the company. Trifecta Capital Advisors LLC acquired a new position in shares of UiPath during the second quarter worth $27,000. CoreCap Advisors LLC boosted its holdings in shares of UiPath by 68.7% during the 3rd quarter. CoreCap Advisors LLC now owns 2,679 shares of the company's stock valued at $34,000 after acquiring an additional 1,091 shares in the last quarter. Versant Capital Management Inc boosted its holdings in shares of UiPath by 103.6% during the 3rd quarter. Versant Capital Management Inc now owns 4,845 shares of the company's stock valued at $62,000 after acquiring an additional 2,465 shares in the last quarter. Global Retirement Partners LLC acquired a new stake in shares of UiPath during the 2nd quarter valued at $57,000. Finally, Blue Trust Inc. boosted its holdings in shares of UiPath by 987.1% during the 1st quarter. Blue Trust Inc. now owns 7,392 shares of the company's stock valued at $82,000 after acquiring an additional 6,712 shares in the last quarter. Institutional investors and hedge funds own 62.50% of the company's stock.
UiPath Stock Down 3.1%
Shares of NYSE:PATH opened at $13.75 on Friday. The business has a fifty day simple moving average of $14.35 and a 200 day simple moving average of $12.45. UiPath, Inc. has a 12-month low of $9.20 and a 12-month high of $19.84. The firm has a market cap of $7.17 billion, a P/E ratio of 20.52, a P/E/G ratio of 1.33 and a beta of 1.01.
UiPath (NYSE:PATH - Get Free Report) last posted its quarterly earnings data on Thursday, September 3rd. The company reported $0.15 earnings per share for the quarter, hitting the consensus estimate of $0.15. The company had revenue of $410.26 million during the quarter, compared to analysts' expectations of $397.77 million. UiPath had a net margin of 21.03% and a return on equity of 9.70%. UiPath's revenue for the quarter was up 13.3% compared to the same quarter last year. During the same period in the prior year, the company posted $0.15 earnings per share. As a group, equities research analysts expect that UiPath, Inc. will post 0.49 EPS for the current year.
Analyst Upgrades and Downgrades
PATH has been the topic of several research reports. Truist Financial reduced their price target on UiPath from $17.00 to $14.00 and set a "hold" rating on the stock in a report on Wednesday, September 23rd. UBS Group lowered their price objective on UiPath from $19.00 to $14.00 and set a "neutral" rating for the company in a research note on Friday, September 25th. BMO Capital Markets dropped their price objective on shares of UiPath from $18.00 to $15.00 and set a "market perform" rating for the company in a report on Thursday, September 24th. KeyCorp reiterated a "sector weight" rating on shares of UiPath in a research report on Thursday, September 24th. Finally, Mizuho boosted their target price on shares of UiPath from $12.00 to $14.00 and gave the stock a "neutral" rating in a report on Friday, September 4th. Four investment analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and two have issued a Sell rating to the company's stock. Based on data from MarketBeat, UiPath presently has a consensus rating of "Hold" and a consensus target price of $15.69.
Get Our Latest Analysis on UiPath
Insider Transactions at UiPath
In other news, insider Raghavendra Malpani sold 29,565 shares of the business's stock in a transaction dated Thursday, October 22nd. The shares were sold at an average price of $14.00, for a total transaction of $413,910.00. Following the completion of the sale, the insider directly owned 1,484,716 shares of the company's stock, valued at $20,786,024. The trade was a 1.95% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Daniel Dines sold 1,250,000 shares of the business's stock in a transaction that occurred on Thursday, October 15th. The stock was sold at an average price of $13.44, for a total value of $16,800,000.00. Following the sale, the chief executive officer directly owned 30,241,238 shares of the company's stock, valued at $406,442,238.72. This represents a 3.97% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 2,962,735 shares of company stock worth $43,584,098. 22.44% of the stock is currently owned by insiders.
About UiPath
(
Free Report)
UiPath, Inc develops enterprise automation software that helps organizations automate repetitive, rules-based and increasingly complex business processes. Its platform combines robotic process automation with artificial intelligence, workflow orchestration, process mining, document processing and application integration capabilities.
The company's products are designed to support the discovery, development, deployment and management of software robots and AI-powered automations across functions such as finance, customer service, human resources, information technology and operations.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.